Oxford DeLIVER research attracts 1000 patients for innovative Pearl clinical study
30 May 2023
1000 patients have been recruited for the Pearl study within the DeLIVER programme.
Cancer at Oxford
29 September 2022
Barnes Boccellato Schuster-Böckler Song Van den Eynde
Read about how Oxford's experts - including Ludwig Oxford scientists - are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series
Ludwig Oxford retreat 2022 – a recap
15 July 2022
Barnes Boccellato Byrne Constantinescu De Val Goding Kriaucionis Lu Mehdipour Moura Alves Ratcliffe Schuster-Böckler Shi Song Van den Eynde
On 13-14th June 2022, the Oxford Branch of the Ludwig Institute for Cancer Research held their annual retreat to discuss key scientific advances within the Branch and beyond.
First major UK prospective study for liver cancer underway
2 March 2022
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme led by Ludwig adjunct Professor Ellie Barnes.
Liver immunologist Professor Ellie Barnes joins Ludwig Oxford as Adjunct Scholar
21 September 2021
Ludwig Oxford welcomes Ellie Barnes to our community, which she has joined as a Ludwig Adjunct Scholar.
TAPS for cancer detection
1 September 2021
TAPS technology has been optimised for mapping DNA methylation on circulating cell-free DNA.